# IRON (Disc Medicine, Inc.) - SEC EDGAR Financial Statements

> Disc Medicine, Inc. reported $699.5M in total assets and a net loss of $243.1M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IRON
- Markdown: https://convexityos.com/fundamentals/IRON.md
- SEC CIK: 0001816736
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:19 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001816736&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$265.7M | Operating profit |
| Net Income | FY 2025 | -$243.1M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$6.25 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$190.0M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $682.8M | Total debt: $61.09M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $170.6M | $96.67M | $69.26M | $33.44M | $25.17M | $28.17M |
| Selling, General & Admin | $65.38M | $33.05M | $21.86M | -- | -- | -- |
| Total Operating Expenses | $236.0M | $129.7M | $91.12M | $47.48M | $30.93M | $34.04M |
| **Operating Income** | -$236.0M | -$129.7M | -$91.12M | -$47.48M | -$30.93M | -$34.04M |
| **EBITDA** | -$235.7M | -$129.6M | -$91.03M | -$47.39M | -$30.90M | -$33.72M |
| Interest Income | $27.76M | $21.29M | $14.80M | $709K | $14K | $37K |
| Interest Expense | $3.61M | $572K | $0 | -- | $2.16M | $6.83M |
| Income Before Tax | -$211.8M | -$109.0M | -$76.33M | -$46.83M | -- | -- |
| Income Tax Expense | $361K | $355K | $99K | $0 | -- | -- |
| **Net Income** | -$212.2M | -$109.4M | -$76.43M | -$46.83M | -$35.97M | -$40.84M |
| Basic EPS | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | -$2.70 |
| **Diluted EPS** | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | -$2.70 |
| Basic Shares Outstanding | 35.3M | 27.6M | 22.3M | 1.0M | 878.4K | 15.1M |
| Diluted Shares Outstanding | 35.3M | 27.6M | 22.3M | 1.0M | 878.4K | 15.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $44.08M | $46.93M | $45.90M | $46.22M | $50.33M | $46.32M | $27.76M | $24.80M |
| Selling, General & Admin | $20.08M | $18.14M | $23.62M | $20.75M | $17.36M | $15.09M | $12.18M | $9.75M |
| Total Operating Expenses | $64.16M | $65.08M | $69.52M | $66.97M | $67.70M | $61.41M | $39.95M | $34.55M |
| **Operating Income** | -$64.16M | -$65.08M | -$69.52M | -$66.97M | -$67.70M | -$61.41M | -$39.95M | -$34.55M |
| **EBITDA** | -$64.07M | -$64.98M | -$69.44M | -$66.88M | -$67.61M | -$61.33M | -$39.93M | -$34.54M |
| Interest Income | $6.45M | $6.53M | $6.89M | $7.41M | $6.41M | $7.06M | $6.88M | $5.84M |
| Interest Expense | $1.71M | $908K | $844K | $883K | $917K | $910K | $897K | $572K |
| Income Before Tax | -$59.43M | -$59.46M | -$63.45M | -$60.44M | -$62.22M | -$55.20M | -$33.97M | -$29.28M |
| Income Tax Expense | $109K | $69K | $51K | $88K | $102K | $52K | $119K | $176K |
| **Net Income** | -$59.53M | -$59.53M | -$63.50M | -$60.53M | -$62.32M | -$55.25M | -$34.09M | -$29.46M |
| Basic EPS | -$1.53 | -$1.54 | -$1.65 | -- | -$1.77 | -$1.58 | -$1.02 | -- |
| **Diluted EPS** | -$1.53 | -$1.54 | -$1.65 | -- | -$1.77 | -$1.58 | -$1.02 | -- |
| Basic Shares Outstanding | 38.9M | 38.7M | 38.5M | -- | 35.2M | 35.0M | 33.3M | -- |
| Diluted Shares Outstanding | 38.9M | 38.7M | 38.5M | -- | 35.2M | 35.0M | 33.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $91.14M | $192.4M | $360.4M | $194.6M | $88.04M | $4.50M |
| Short-Term Investments | $700.0M | $297.4M | $0 | -- | -- | -- |
| **Cash & Short-Term Investments** | $791.2M | $489.9M | $360.4M | $194.6M | $88.04M | $4.50M |
| **Total Current Assets** | $803.9M | $493.6M | $365.7M | $198.5M | $90.48M | $5.07M |
| Property, Plant & Equipment, Net | $1.16M | $751K | $170K | $168K | $106K | $294K |
| Other Non-Current Assets | $726K | $838K | $234K | $116K | $180K | -- |
| **Total Non-Current Assets** | $2.98M | $3.16M | $2.33M | $1.71M | $1.93M | $3.25M |
| **Total Assets** | $806.9M | $496.8M | $368.0M | $200.2M | $92.41M | $8.32M |
| Accounts Payable | $9.02M | $7.95M | $12.63M | $16.16M | $2.56M | $2.38M |
| Short-Term Debt | -- | -- | -- | -- | -- | $0 |
| **Total Current Liabilities** | $36.64M | $23.32M | $21.44M | $22.58M | $13.42M | $24.88M |
| Long-Term Debt | $29.16M | $28.32M | $0 | -- | -- | $2.31M |
| **Total Non-Current Liabilities** | $30.41M | $29.87M | $1.44M | $1.03M | $1.33M | $5.30M |
| **Total Liabilities** | $67.05M | $53.19M | $22.88M | $23.61M | $14.76M | $30.18M |
| **Total Debt (incl. Leases)** | $30.68M | $30.00M | $2.10M | $1.33M | $1.65M | $2.31M |
| Common Stock | $4.0K | $3.0K | $2.0K | $2.0K | $0 | $2.0K |
| Retained Earnings | -$510.2M | -$298.0M | -$188.6M | -$112.2M | -$65.39M | -$112.8M |
| Accumulated Other Comp. Income | $965K | $289K | $0 | -- | -- | -- |
| **Total Stockholders' Equity** | $739.8M | $443.6M | $345.1M | $176.6M | -$64.20M | -$28.81M |
| Total Equity | $739.8M | $443.6M | $345.1M | $176.6M | -$64.20M | -$28.81M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $89.98M | $98.68M | $88.91M | $91.14M | $140.7M | $127.3M | $122.7M | $192.4M |
| Short-Term Investments | $592.8M | $619.1M | $641.2M | $700.0M | $475.3M | $522.6M | $572.0M | $297.4M |
| **Cash & Short-Term Investments** | $682.8M | $717.7M | $730.2M | $791.2M | $615.9M | $650.0M | $694.7M | $489.9M |
| **Total Current Assets** | $697.4M | $732.8M | $747.5M | $803.9M | $627.2M | $661.6M | $705.6M | $493.6M |
| Property, Plant & Equipment, Net | $890K | $980K | $1.07M | $1.16M | $1.23M | $1.29M | $1.37M | $751K |
| Other Non-Current Assets | $496K | $496K | $721K | $726K | $840K | $840K | $839K | $838K |
| **Total Non-Current Assets** | $2.08M | $2.31M | $2.76M | $2.98M | $3.29M | $3.47M | $3.67M | $3.16M |
| **Total Assets** | $699.5M | $735.1M | $750.2M | $806.9M | $630.5M | $665.1M | $709.3M | $496.8M |
| Accounts Payable | $6.07M | $6.84M | $11.76M | $9.02M | $7.27M | $6.35M | $6.70M | $7.95M |
| **Total Current Liabilities** | $34.36M | $30.36M | $31.14M | $36.64M | $26.74M | $20.61M | $18.74M | $23.32M |
| Long-Term Debt | $59.74M | $59.34M | $29.36M | $29.16M | $28.95M | $28.74M | $28.53M | $28.32M |
| **Total Non-Current Liabilities** | $60.88M | $60.55M | $30.64M | $30.41M | $30.32M | $30.29M | $30.16M | $29.87M |
| **Total Liabilities** | $95.24M | $90.91M | $61.78M | $67.05M | $57.06M | $50.90M | $48.90M | $53.19M |
| **Total Debt (incl. Leases)** | $61.09M | $60.86M | $31.06M | $30.68M | $30.98M | $30.92M | $30.64M | $30.00M |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K |
| Retained Earnings | -$692.8M | -$633.2M | -$573.7M | -$510.2M | -$449.7M | -$387.3M | -$332.1M | -$298.0M |
| Accumulated Other Comp. Income | -$2.77M | -$1.61M | -$571K | $965K | $718K | $273K | $535K | $289K |
| **Total Stockholders' Equity** | $604.2M | $644.2M | $688.4M | $739.8M | $573.4M | $614.2M | $660.4M | $443.6M |
| Total Equity | $604.2M | $644.2M | $688.4M | $739.8M | $573.4M | $614.2M | $660.4M | $443.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$212.2M | -$109.4M | -$76.43M | -$46.83M | -$35.97M | -$40.84M |
| Depreciation & Amortization | $281K | $156K | $100K | $89K | $32K | $322K |
| Stock-Based Compensation | $34.34M | $16.82M | $5.53M | $2.09M | $507K | $983K |
| Change in Payables | $1.07M | -$4.68M | -$3.74M | $526K | $1.31M | -$2.41M |
| **Operating Cash Flow** | -$180.4M | -$93.93M | -$73.46M | -$42.25M | -$27.53M | -$32.71M |
| Capital Expenditure | -$933K | -$505K | -$89K | -$151K | -$68K | -$22K |
| **Free Cash Flow** | -$181.3M | -$94.43M | -$73.55M | -$42.40M | -$27.60M | -$32.73M |
| Purchases of Investments | -$849.6M | -$386.6M | $0 | -- | -- | -- |
| **Investing Cash Flow** | -$394.3M | -$292.3M | -$89K | -$151K | -$68K | -$22K |
| Common Stock Issued | -- | -- | $0 | $53.50M | $0 | $20.08M |
| **Financing Cash Flow** | $473.4M | $218.3M | $239.4M | $149.0M | $89.93M | $34.25M |
| **Net Change in Cash** | -$101.3M | -$167.9M | $165.8M | $106.6M | $62.33M | $1.52M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$59.53M | -$59.53M | -$63.50M | -$60.53M | -$62.32M | -$55.25M | -$34.09M | -$29.46M |
| Depreciation & Amortization | $90K | $90K | $89K | $89K | $87K | $85K | $20K | $9.0K |
| Stock-Based Compensation | $14.61M | $13.95M | $11.95M | $10.04M | $9.51M | $8.42M | $6.36M | $4.33M |
| Change in Payables | -$766K | -$4.92M | $2.74M | $1.75M | $918K | -$321K | -$1.28M | $4.39M |
| **Operating Cash Flow** | -$40.20M | -$44.20M | -$62.24M | -$43.30M | -$47.80M | -$47.92M | -$41.38M | -$27.57M |
| Capital Expenditure | $0 | $0 | $0 | -$20K | -$26K | -$36K | -$851K | -$449K |
| **Free Cash Flow** | -$40.20M | -$44.20M | -$62.24M | -$43.32M | -$47.83M | -$47.95M | -$42.23M | -$28.02M |
| Purchases of Investments | -$118.5M | -$92.73M | -$93.76M | -$358.3M | -$85.44M | -$58.63M | -$347.2M | -$72.78M |
| **Investing Cash Flow** | $25.33M | $21.63M | $58.31M | -$222.9M | $49.54M | $51.69M | -$272.6M | -$1.43M |
| **Financing Cash Flow** | $6.18M | $32.34M | $1.70M | $216.7M | $11.59M | $892K | $244.3M | $28.80M |
| **Net Change in Cash** | -$8.69M | $9.76M | -$2.23M | -$49.52M | $13.33M | $4.66M | -$69.76M | -$202K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -28.7% | -24.7% | -22.1% | -26.5% | -- | -- |
| Return on Assets (ROA) | -26.3% | -22.0% | -20.8% | -23.4% | -38.9% | -490.9% |
| Current Ratio | 21.94x | 21.17x | 17.06x | 8.79x | 6.74x | 0.20x |
| Quick Ratio | 21.59x | 21.01x | 16.81x | 8.62x | 6.56x | 0.18x |
| Debt to Equity | 0.04x | 0.07x | 0.01x | 0.01x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -40.2% | -38.2% | -35.1% | -28.7% | -31.6% | -23.7% | -17.6% | -24.7% |
| Return on Assets (ROA) | -34.8% | -33.5% | -32.2% | -26.3% | -28.7% | -21.9% | -16.4% | -22.0% |
| Current Ratio | 20.30x | 24.14x | 24.00x | 21.94x | 23.45x | 32.11x | 37.65x | 21.17x |
| Quick Ratio | 19.87x | 23.64x | 23.45x | 21.59x | 23.03x | 31.54x | 37.07x | 21.01x |
| Debt to Equity | 0.10x | 0.09x | 0.05x | 0.04x | 0.05x | 0.05x | 0.05x | 0.07x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
